Edward Maldonado • UCSF Profiles (original) (raw)
Title(s)Assistant Professor, MedicineSchoolSchool of MedicineAddress1825 4th Street, #L6101San Francisco CA 94158PronounsHe/Him/His ORCID.gif) 0000-0002-7018-8462  vCardDownload vCard |
|---|
Biography
| University of Portland, Portland, OR. | BS | 2012 | Biology (Minor in Chemistry) |
|---|---|---|---|
| Creighton University School of Medicine, Omaha, NE. | MD | 2017 | |
| Oregon Health and Science University, Portland, OR. Internship in Internal Medicine | 2018 | ||
| Oregon Health and Science University, Portland, OR. Residency in Internal Medicine | 2020 | ||
| Oregon Health and Science University, Portland, OR. Chief Resident in Internal Medicine | 2021 | ||
| University of California, San Francisco, San Francisco, CA Fellowship in Hematology/Medical Oncology | 2024 | ||
| University of California, San Francisco, San Francisco, CA Chief Fellow in Hematology/Medical Oncology | 2023 |
| University of California, San Francisco, Department of Medicine, Division of Internal Medicine | 2023 - | 2023 | UCSF Internal Medicine Residency Hematology/Oncology Fellow Teaching Award |
|---|---|---|---|
| University of California, San Francisco, Department of Medicine, Division of Hematology and Medical Oncology | 2022 - | 2022 | UCSF Rachel Pearline Award: awarded to a hematology/oncology fellow who demonstrates an extraordinary commitment to patient care and embodies Rachel's deep humanism. |
| Oregon Health and Science University, Department of Medicine, Division of Internal Medicine | 2021 - | 2021 | OHSU Professional Board Outstanding Contribution to Education and Research |
| Oregon Health and Science University, Department of Medicine, Division of Internal Medicine | 2020 - | 2020 | Thomas J. & Nancy Fitzgerald Stack Award: a merit-based humanism award in recognition of integrity, dedication, and selflessness in caring for patients. |
| Oregon Health and Science University, Department of Medicine, Division of Internal Medicine | 2020 - | 2020 | OHSU Medical Housestaff Teaching Award |
| University of Portland, Department of Biology | 2012 - | 2012 | Becky Houck Award for Outstanding Teaching Assistance, Mentoring, and Service |
Overview
I am a Medical Oncologist within the Division of Hematology/Oncology at the University of California, San Francisco. My clinical practice focuses on care of adults with genitourinary cancers, including prostate, bladder, kidney, and testicular cancer.
My research interests include clinical trials to evaluate promising treatments for patients with genitourinary cancers, with particular interests in advanced prostate cancer and DNA damage repair therapies. I have also participated in quality improvement projects centered around fertility preservation and medical education.
ORNG Applications
Bibliographic
Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.)Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication.Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
- A Phase II Trial of the WEE1 Inhibitor Adavosertib in SETD2-Altered Advanced Solid Tumor Malignancies (NCI 10170). Cancer Res Commun. 2024 07 01; 4(7):1793-1801. Maldonado E, Rathmell WK, Shapiro GI, Takebe N, Rodon J, Mahalingam D, Trikalinos NA, Kalebasty AR, Parikh M, Boerner SA, Balido C, Krings G, Burns TF, Bergsland EK, Munster PN, Ashworth A, LoRusso P, Aggarwal RR. PMID: 38920407; PMCID: PMC11264598.
View in: PubMed Mentions: 6 Fields:
Translation:HumansCTClinical Trials - Impact of Squamous Histology on Clinical Outcomes and Molecular Profiling in Metastatic Urothelial Carcinoma Patients Treated With Immune Checkpoint Inhibitors or Enfortumab Vedotin. Clin Genitourin Cancer. 2023 10; 21(5):e394-e404. Jindal T, Zhang L, Deshmukh P, Reyes K, Chan E, Kumar V, Zhu X, Maldonado E, Feng S, Johnson M, Angelidakis A, Kwon D, Desai A, Borno HT, Bose R, Wong A, Hong J, Carroll P, Meng M, Porten S, Aggarwal R, Small EJ, Fong L, Chou J, Friedlander T, de Kouchkovsky I, Koshkin VS. PMID: 37316414.
View in: PubMed Mentions: 8 Fields:
Translation:Humans - Somatic alterations of TP53 and MDM2 associated with response to enfortumab vedotin in patients with advanced urothelial cancer. Front Oncol. 2023; 13:1161089. Jindal T, Zhu X, Bose R, Kumar V, Maldonado E, Deshmukh P, Shipp C, Feng S, Johnson MS, Angelidakis A, Kwon D, Borno HT, de Kouchkovsky I, Desai A, Aggarwal R, Fong L, Small EJ, Wong A, Porten S, Chou J, Friedlander T, Koshkin VS. PMID: 37091148; PMCID: PMC10113661.
View in: PubMed Mentions: 9 - Early relapse identifies MCL patients with inferior survival after intensive or less intensive frontline therapy. Blood Adv. 2021 12 14; 5(23):5179-5189. Bond DA, Switchenko JM, Villa D, Maddocks K, Churnetski M, Gerrie AS, Goyal S, Shanmugasundaram K, Calzada O, Kolla B, Bachanova V, Gerson JN, Barta SK, Hill BT, Sawalha Y, Martin P, Maldonado E, Gordon M, Danilov AV, Grover NS, Mathews S, Burkart M, Karmali R, Ghosh N, Park SI, Epperla N, Badar T, Guo J, Hamadani M, Fenske TS, Malecek MK, Kahl BS, Flowers CR, Blum KA, Cohen JB. PMID: 34516611; PMCID: PMC9153047.
View in: PubMed Mentions: 21 Fields:
Translation:Humans - Antithrombotic Therapies in COVID-19 Disease: a Systematic Review. J Gen Intern Med. 2020 Sep; 35(9):2698-2706. Maldonado E, Tao D, Mackey K. PMID: 32556875; PMCID: PMC7299557.
View in: PubMed Mentions: 21 Fields:
Translation:HumansCellsPHPublic Health - Estimation of US patients with cancer who may respond to cytotoxic chemotherapy. Future Sci OA. 2020 May 25; 6(8):FSO600. Maldonado EB, Parsons S, Chen EY, Haslam A, Prasad V. PMID: 32983564; PMCID: PMC7491026.
View in: PubMed Mentions: 14 - Comparison of Drugs Used for Adjuvant and Metastatic Therapy of Colon, Breast, and Non-Small Cell Lung Cancers. JAMA Netw Open. 2020 04 01; 3(4):e202488. Parsons S, Maldonado EB, Prasad V. PMID: 32275321; PMCID: PMC7148439.
View in: PubMed Mentions: 14 Fields:
Translation:Humans - Refractory Autoimmune Cytopenias Treated With Venetoclax. Hemasphere. 2019 Jun; 3(3):e202. Gordon MJ, Maldonado E, Danilov AV. PMID: 31723832; PMCID: PMC6746017.
View in: PubMed Mentions: 8 - Treatment Patterns and Outcomes in Early-stage Hodgkin Lymphoma in the Elderly: A National Cancer Database Analysis. Clin Lymphoma Myeloma Leuk. 2017 Dec; 17(12):812-818. Goyal G, Maldonado EB, Fan TJ, Kanmanthareddy A, Silberstein PT, Go RS, Armitage JO. PMID: 28988670.
View in: PubMed Mentions: 3 Fields:
Translation:Humans - The human immunodeficiency virus transactivator Tat interacts with the RNA polymerase II holoenzyme. Mol Cell Biol. 1997 Apr; 17(4):1817-23. Cujec TP, Cho H, Maldonado E, Meyer J, Reinberg D, Peterlin BM. PMID: 9121429; PMCID: PMC232028.
View in: PubMed Mentions: 47 Fields:
Translation:HumansAnimalsCells
This graph shows the total number of publications by year. To see the data as text, click here.
This graph shows the total number of publications by year. To return to the graph, click here.
| Year | Publications |
|---|---|
| 1997 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 1 |
| 2023 | 2 |
| 2024 | 1 |
This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
Start with: newest oldestInclude: line numbers double spacing all authors publication IDs
Concepts (59)
Derived automatically from this person's publications.
_
Co-Authors (29)
People in Profiles who have published with this person.
_
Similar People (60)
People who share similar concepts with this person.
_
_